This inventor holds 1 USPTO granted patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Emile Benechie: Innovator in Cancer Treatment
Introduction
Emile Benechie is a notable inventor based in GIF S/Yvette, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of pyranone derivatives. His work is recognized for its potential therapeutic applications in combating cancer.
Latest Patents
Emile Benechie holds a patent for pyranone derivatives useful for treating cancer. The invention relates to pyranone derivatives of general formula (I), wherein X is chlorine, bromine, or iodine, and R and R' are independently a hydrogen atom, an alkyl, cycloalkyl, or alkylene group containing 1-20 carbon atoms. These groups may be optionally substituted by a hydroxyl, amino, ether, or halogen group. Additionally, R and R' can form a cycle of 5, 6, 7, or 8 members, which is also optionally substituted. The patent includes isomers, enantiomers, diastereoisomers, and their mixtures. A method for preparing these inventive derivatives and their therapeutic use, particularly for treating cancer, is also disclosed. Emile Benechie has 1 patent to his name.
Career Highlights
Emile Benechie is affiliated with the Centre National de la Recherche Scientifique, where he conducts his research. His work is characterized by a strong focus on developing innovative solutions for complex medical challenges, particularly in oncology.
Collaborations
Emile has collaborated with several professionals in his field, including Catherine Marie Germaine Magnan, who serves as a Legal Representative, and Françoise Khuong-Huu. These collaborations enhance the impact of his research and contribute to the advancement of cancer treatment methodologies.
Conclusion
Emile Benechie is a dedicated inventor whose work in developing pyranone derivatives showcases his commitment to improving cancer treatment. His contributions to the scientific community are invaluable and highlight the importance of innovation in healthcare.
